Classification Term: 170448
Amino cyclitols (ontology term: 9bfb7c25e6d1aac81d49204670eab3f6)
found 214 associated metabolites at sub_class metabolite taxonomy ontology rank level.
Ancestor: Polyols
Child Taxonomies: There is no child term of current ontology term.
Kanamycin
C18H36N4O11 (484.23804659999996)
Kanamycin is only found in individuals that have used or taken this drug. It is an antibiotic complex produced by Streptomyces kanamyceticus from Japanese soil. Comprises 3 components: kanamycin A, the major component, and kanamycins B and C, the minor components. [PubChem]Aminoglycosides like kanamycin "irreversibly" bind to specific 30S-subunit proteins and 16S rRNA. Specifically Kanamycin binds to four nucleotides of 16S rRNA and a single amino acid of protein S12. This interferes with decoding site in the vicinity of nucleotide 1400 in 16S rRNA of 30S subunit. This region interacts with the wobble base in the anticodon of tRNA. This leads to interference with the initiation complex, misreading of mRNA so incorrect amino acids are inserted into the polypeptide leading to nonfunctional or toxic peptides and the breakup of polysomes into nonfunctional monosomes. A - Alimentary tract and metabolism > A07 - Antidiarrheals, intestinal antiinflammatory/antiinfective agents > A07A - Intestinal antiinfectives > A07AA - Antibiotics J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01G - Aminoglycoside antibacterials S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AA - Antibiotics C784 - Protein Synthesis Inhibitor > C2363 - Aminoglycoside Antibiotic D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic
Tobramycin
Tobramycin is only found in individuals that have used or taken this drug. It is an aminoglycoside, broad-spectrum antibiotic produced by Streptomyces tenebrarius. It is effective against gram-negative bacteria, especially the pseudomonas species. It is a 10\\\% component of the antibiotic complex, nebramycin, produced by the same species. [PubChem]Tobramycin binds irreversibly to one of two aminoglycoside binding sites on the 30 S ribosomal subunit, inhibiting bacterial protein synthesis. Tobramycin may also destabilize bacterial memebrane by binding to 16 S 16 S r-RNA. An active transport mechanism for aminoglycoside uptake is necessary in the bacteria in order to attain a significant intracellular concentration of tobramycin. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01G - Aminoglycoside antibacterials S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AA - Antibiotics C784 - Protein Synthesis Inhibitor > C2363 - Aminoglycoside Antibiotic D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic Tobramycin (Nebramycin Factor 6) is a parenterally administered, broad spectrum aminoglycoside antibiotic that is widely used in the treatment of moderate to severe bacterial infections due to sensitive organisms[1].Tobramycin can be used to pneumonia research caused by Pseudomonas aeruginosa[2][3].
Streptomycin
Streptomycin is an aminoglycoside antibiotic produced by the soil actinomycete Streptomyces griseus. It acts by binding to the 30S ribosomal subunit of susceptible organisms and disrupting the initiation and elongation steps in protein synthesis. It is bactericidal due to effects that are not fully understood. A - Alimentary tract and metabolism > A07 - Antidiarrheals, intestinal antiinflammatory/antiinfective agents > A07A - Intestinal antiinfectives > A07AA - Antibiotics J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01G - Aminoglycoside antibacterials > J01GA - Streptomycins C784 - Protein Synthesis Inhibitor > C2363 - Aminoglycoside Antibiotic D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic KEIO_ID S031
Sisomicin
J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01G - Aminoglycoside antibacterials D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D005839 - Gentamicins C784 - Protein Synthesis Inhibitor > C2363 - Aminoglycoside Antibiotic D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors C254 - Anti-Infective Agent > C258 - Antibiotic KEIO_ID S047; [MS3] KO009246 KEIO_ID S047; [MS2] KO009245 KEIO_ID S047
Kanamycin B
J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01G - Aminoglycoside antibacterials C784 - Protein Synthesis Inhibitor > C2363 - Aminoglycoside Antibiotic D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic KEIO_ID B028 Bekanamycin (Kanamycin B) is an aminoglycoside antibiotic produced by Streptomyces kanamyceticus, against an array of Gram-positive and Gram-negative bacterial strain[1][2].
2-Deoxystreptamine
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents KEIO_ID D061
Dihydrostreptomycin
C21H41N7O12 (583.2813066000001)
S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AA - Antibiotics C784 - Protein Synthesis Inhibitor > C2363 - Aminoglycoside Antibiotic D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic Origin: Microbe, Glycosides, Aminoglycosides KEIO_ID D108; [MS2] KO008925 KEIO_ID D108
Neomycin
C23H46N6O13 (614.3122705999999)
A component of neomycin that is produced by Streptomyces fradiae. On hydrolysis it yields neamine and neobiosamine B. (From Merck Index, 11th ed). Neomycin is a bactericidal aminoglycoside antibiotic that binds to the 30S ribosome of susceptible organisms. Binding interferes with mRNA binding and acceptor tRNA sites and results in the production of non-functional or toxic peptides. A - Alimentary tract and metabolism > A01 - Stomatological preparations > A01A - Stomatological preparations > A01AB - Antiinfectives and antiseptics for local oral treatment A - Alimentary tract and metabolism > A07 - Antidiarrheals, intestinal antiinflammatory/antiinfective agents > A07A - Intestinal antiinfectives > A07AA - Antibiotics B - Blood and blood forming organs > B05 - Blood substitutes and perfusion solutions > B05C - Irrigating solutions > B05CA - Antiinfectives D - Dermatologicals > D09 - Medicated dressings > D09A - Medicated dressings > D09AA - Medicated dressings with antiinfectives D - Dermatologicals > D06 - Antibiotics and chemotherapeutics for dermatological use > D06A - Antibiotics for topical use S - Sensory organs > S03 - Ophthalmological and otological preparations > S03A - Antiinfectives > S03AA - Antiinfectives R - Respiratory system > R01 - Nasal preparations > R01A - Decongestants and other nasal preparations for topical use J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01G - Aminoglycoside antibacterials R - Respiratory system > R02 - Throat preparations > R02A - Throat preparations > R02AB - Antibiotics S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AA - Antibiotics S - Sensory organs > S02 - Otologicals > S02A - Antiinfectives > S02AA - Antiinfectives C784 - Protein Synthesis Inhibitor > C2363 - Aminoglycoside Antibiotic D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic KEIO_ID N022
Paromomycin
Paromomycin is only found in individuals that have used or taken this drug. It is an oligosaccharide antibiotic produced by various streptomyces. [PubChem]Paromomycin inhibits protein synthesis by binding to 16S ribosomal RNA. Bacterial proteins are synthesized by ribosomal RNA complexes which are composed of 2 subunits, a large subunit (50s) and small (30s) subunit, which forms a 70s ribosomal subunit. tRNA binds to the top of this ribosomal structure. Paramomycin binds to the A site, which causes defective polypeptide chains to be produced. Continuous production of defective proteins eventually leads to bacterial death. A - Alimentary tract and metabolism > A07 - Antidiarrheals, intestinal antiinflammatory/antiinfective agents > A07A - Intestinal antiinfectives > A07AA - Antibiotics D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C784 - Protein Synthesis Inhibitor > C2363 - Aminoglycoside Antibiotic D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic KEIO_ID P126
neamine
C12H26N4O6 (322.18522559999997)
C784 - Protein Synthesis Inhibitor > C2363 - Aminoglycoside Antibiotic C254 - Anti-Infective Agent > C258 - Antibiotic
Hygromycin B
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000871 - Anthelmintics D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents Hygromycin B is an aminoglycoside antibiotic active against prokaryotic and eukaryotic cells.
Gentamicin A
C18H36N4O10 (468.24313159999997)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D005839 - Gentamicins
Gentamicin
A complex of three different closely related aminoglycoside sulfates, Gentamicins C1, C2, and C1(subA), obtained from Micromonospora purpurea and related species. They are broad-spectrum antibiotics, but may cause ear and kidney damage. They act to inhibit protein synthesis (genetic translation). [PubChem] D - Dermatologicals > D06 - Antibiotics and chemotherapeutics for dermatological use > D06A - Antibiotics for topical use S - Sensory organs > S03 - Ophthalmological and otological preparations > S03A - Antiinfectives > S03AA - Antiinfectives J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01G - Aminoglycoside antibacterials S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AA - Antibiotics D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D005839 - Gentamicins S - Sensory organs > S02 - Otologicals > S02A - Antiinfectives > S02AA - Antiinfectives C784 - Protein Synthesis Inhibitor > C2363 - Aminoglycoside Antibiotic D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors C254 - Anti-Infective Agent > C258 - Antibiotic
Gentamicin X2
C19H38N4O10 (482.25878079999995)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D005839 - Gentamicins
Astromicin
C17H35N5O6 (405.25872100000004)
An amino cyclitol glycoside that is L-chiro-inositol in which the hydroxy groups at positions 1, 4, and 6 are replaced by aminoacetyl)methylamino, amino, and methoxy groups, respectively, and in which the hydroxy group at position 3 is converted to the corresponding 2,6-diamino-2,3,4,6,7-pentadeoxy-beta-L-lyxo-heptopyranoside. The major component of fortimicin, obtained from Micromonospora olivasterospora. It is administered (as the sulfate salt) by intramuscular injection or intravenous infusion for the treatment of severe systemic infections due to sensitive Gram-negative organisms. C784 - Protein Synthesis Inhibitor > C2363 - Aminoglycoside Antibiotic C254 - Anti-Infective Agent > C258 - Antibiotic
Validamycin B
Active against rice sheath blight disease and Pellicularia sasakii. Active against rice sheath blight disease and Pellicularia sasakii
Hygromycin B
Hygromycin B is a fda approved antibiotic food additive for swine and poultry Hygromycin B is an antibiotic produced by the bacterium Streptomyces hygroscopicus. It is an aminoglycoside that kills bacteria, fungi and higher eukaryotic cells by inhibiting protein synthesis. In the laboratory it is used for the selection and maintenance of prokaryotic and eukaryotic cells that contain the hygromycin resistance gene. The resistance gene is a kinase that inactivates hygromycin B through phosphorylation. Since the discovery of hygromycin-resistance genes, hygromycin B has become a standard selection antibiotic in gene transfer experiments in many prokaryotic and eukaryotic cells D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000871 - Anthelmintics D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents FDA approved antibiotic food additive for swine and poultry Hygromycin B is an aminoglycoside antibiotic active against prokaryotic and eukaryotic cells.
DG(19:0/8:0/0:0)
DG(19:0/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(19:0/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
Paromomycin I
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents
geneticin
C20H40N4O10 (496.27443000000005)
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D005839 - Gentamicins
Neomycin sulfate
C23H46N6O13 (614.3122705999999)
Astromicin
C17H35N5O6 (405.25872100000004)
Dactimicin
Dihydrostreptomycin
C21H41N7O12 (583.2813066000001)
Neamine
C12H26N4O6 (322.18522559999997)
ribostamycin
Streptomycin sulfate
Lividomycin A
A member of the class of lividomycins that is lividomycin B in which position 4 of the diamino-L-idopyranosyl moiety has been converted into its alpha-D-mannopyranoside. C784 - Protein Synthesis Inhibitor > C2363 - Aminoglycoside Antibiotic C254 - Anti-Infective Agent > C258 - Antibiotic
kanamycin
C18H36N4O11 (484.23804659999996)
A - Alimentary tract and metabolism > A07 - Antidiarrheals, intestinal antiinflammatory/antiinfective agents > A07A - Intestinal antiinfectives > A07AA - Antibiotics J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01G - Aminoglycoside antibacterials S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AA - Antibiotics C784 - Protein Synthesis Inhibitor > C2363 - Aminoglycoside Antibiotic D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic Origin: Microbe, Glycosides, Aminoglycosides KEIO_ID K002; [MS2] KO009014 KEIO_ID K002
streptomycin
A - Alimentary tract and metabolism > A07 - Antidiarrheals, intestinal antiinflammatory/antiinfective agents > A07A - Intestinal antiinfectives > A07AA - Antibiotics A amino cyclitol glycoside that consists of streptidine having a disaccharyl moiety attached at the 4-position. The parent of the streptomycin class J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01G - Aminoglycoside antibacterials > J01GA - Streptomycins C784 - Protein Synthesis Inhibitor > C2363 - Aminoglycoside Antibiotic D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic
Tobramycin
J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01G - Aminoglycoside antibacterials A amino cyclitol glycoside that is kanamycin B lacking the 3-hydroxy substituent from the 2,6-diaminoglucose ring. S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AA - Antibiotics C784 - Protein Synthesis Inhibitor > C2363 - Aminoglycoside Antibiotic D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic Tobramycin (Nebramycin Factor 6) is a parenterally administered, broad spectrum aminoglycoside antibiotic that is widely used in the treatment of moderate to severe bacterial infections due to sensitive organisms[1].Tobramycin can be used to pneumonia research caused by Pseudomonas aeruginosa[2][3].
Geneticin
C20H40N4O10 (496.27443000000005)
An aminoglycoside antibiotic produced by Micromonospora rhodorangea. It blocks polypeptide synthesis by inhibiting the elongation step in both prokaryotic and eukaryotic cells.
Neomycin C
C23H46N6O13 (614.3122705999999)
C784 - Protein Synthesis Inhibitor > C2363 - Aminoglycoside Antibiotic C254 - Anti-Infective Agent > C258 - Antibiotic
gentamicin
D - Dermatologicals > D06 - Antibiotics and chemotherapeutics for dermatological use > D06A - Antibiotics for topical use S - Sensory organs > S03 - Ophthalmological and otological preparations > S03A - Antiinfectives > S03AA - Antiinfectives J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01G - Aminoglycoside antibacterials S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AA - Antibiotics D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D005839 - Gentamicins S - Sensory organs > S02 - Otologicals > S02A - Antiinfectives > S02AA - Antiinfectives C784 - Protein Synthesis Inhibitor > C2363 - Aminoglycoside Antibiotic D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors C254 - Anti-Infective Agent > C258 - Antibiotic
Validamycin B
A member of the class of validamycins that is validamycin A in which the pro-R hydrogen at the unsubstituted position of the cycloxexane ring has been replaced by a hydroxy group.
Valienamine
D007004 - Hypoglycemic Agents > D065089 - Glycoside Hydrolase Inhibitors D004791 - Enzyme Inhibitors
Validamycin
C20H35NO13 (497.21083000000004)
Validamycin A, a fungicidal, is an agricultural antibiotic. Validamycin A is originally isolated from Streptomyces hygroscopicus var. limoneus. Validamycin A inhibits the growth of A. flavus, with a MIC of 1?μg/mL[1]. Validamycin A shows potent inhibitory activity against trehalase of Rhizoctonia solani, with an IC50 of 72 μM[2]. Validamycin A is a reversible tyrosinase inhibitor, with a Ki of 5.893 mM[3].
Gentamycin C1
D - Dermatologicals > D06 - Antibiotics and chemotherapeutics for dermatological use > D06A - Antibiotics for topical use S - Sensory organs > S03 - Ophthalmological and otological preparations > S03A - Antiinfectives > S03AA - Antiinfectives J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01G - Aminoglycoside antibacterials S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AA - Antibiotics D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D005839 - Gentamicins S - Sensory organs > S02 - Otologicals > S02A - Antiinfectives > S02AA - Antiinfectives D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors
(1S,3R,4S,6R)-4-amino-6-(hydroxymethyl)cyclohexane-1,3-diol
D007004 - Hypoglycemic Agents > D065089 - Glycoside Hydrolase Inhibitors D004791 - Enzyme Inhibitors
Hygromycin B
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000871 - Anthelmintics D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents Hygromycin B is an aminoglycoside antibiotic active against prokaryotic and eukaryotic cells.
Paromomycin
An amino cyclitol glycoside that is the 1-O-(2-amino-2-deoxy-alpha-D-glucopyranoside) and the 3-O-(2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl)-beta-D-ribofuranoside of 4,6-diamino-2,3-dihydroxycyclohexane (the 1R,2R,3S,4R,6S diastereoisomer). It is obtained from various Streptomyces species. A broad-spectrum antibiotic, it is used (generally as the sulfate salt) for the treatment of acute and chronic intestinal protozoal infections, but is not effective for extraintestinal protozoal infections. It is also used as a therapeutic against visceral leishmaniasis. A - Alimentary tract and metabolism > A07 - Antidiarrheals, intestinal antiinflammatory/antiinfective agents > A07A - Intestinal antiinfectives > A07AA - Antibiotics D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C784 - Protein Synthesis Inhibitor > C2363 - Aminoglycoside Antibiotic D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic
ribostamycin
An amino cyclitol glycoside that is 4,6-diaminocyclohexane-1,2,3-triol having a 2,6-diamino-2,6-dideoxy-alpha-D-glucosyl residue attached at position 1 and a beta-D-ribosyl residue attached at position 2. It is an antibiotic produced by Streptomyces ribosidificus (formerly S. thermoflavus). J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01G - Aminoglycoside antibacterials C784 - Protein Synthesis Inhibitor > C2363 - Aminoglycoside Antibiotic D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic
Destomysin
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000871 - Anthelmintics D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents Hygromycin B is an aminoglycoside antibiotic active against prokaryotic and eukaryotic cells.
n-({[(1s,2r,3r,4s,6s)-4-amino-3-{[(2r,3r,6s)-3-amino-6-[(methylamino)methyl]oxan-2-yl]oxy}-2-hydroxy-6-methoxycyclohexyl](methyl)carbamoyl}methyl)carboximidic acid
C18H35N5O6 (417.25872100000004)
{5-[(3-acetylphenyl)amino]-4-amino-3-[n,n-dimethyl-(c-hydroxycarbonimidoyl)amino]-3-ethyl-1,2-dihydroxy-2-methylcyclopentyl}methyl 2-hydroxy-6-methylbenzoate
(2r,3s,4r,5r,6r)-5-amino-6-{[(2r,3s,4r,5s)-5-{[(1r,2r,3s,5r,6s)-3-amino-2-{[(2r,3r,4r,5s,6r)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy}-5,6-dihydroxycyclohexyl]oxy}-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxy}-2-(aminomethyl)oxane-3,4-diol
n-[4-amino-6-({3-amino-6-[(methylamino)methyl]oxan-2-yl}oxy)-2-hydroxy-3-methoxycyclohexyl]-2-methanimidamido-n-methylacetamide
(2s,3r,4s,5s)-2-{[(1s,2s,3s,4r,5r,6r)-2,4-diamino-5-{[(2s,3r,6r)-3-amino-6-[(methylamino)methyl]oxan-2-yl]oxy}-3,6-dihydroxycyclohexyl]oxy}-5-methyl-4-(methylamino)oxane-3,5-diol
C20H41N5O8 (479.29549860000003)
2,6-dichloro-1-[5,6-dihydroxy-3-(hydroxymethyl)-4-methoxycyclohex-2-en-1-yl]-5-hydroxy-8-methylchromeno[2,3-b]pyrrol-4-one
C20H19Cl2NO7 (455.05385240000004)
n-[(1s,2r,3r,4r,5s,6r)-4-amino-3-{[(2r,3r,6s)-3-amino-6-[(1s)-1-aminoethyl]oxan-2-yl]oxy}-2,5-dihydroxy-6-methoxycyclohexyl]-2-methanimidamido-n-methylacetamide
2-({[1-({4-[(3,5-diamino-6-methyloxan-2-yl)oxy]-2,3,5,6-tetrahydroxycyclohexyl}-c-hydroxycarbonimidoyl)-2-(2-iminoimidazolidin-4-yl)ethyl]-c-hydroxycarbonimidoyl}amino)-4-methylpentanoic acid
3-amino-2-({3-amino-6-[(ethylamino)methyl]oxan-2-yl}oxy)-5-methoxy-6-(methylamino)cyclohexan-1-ol
C16H34N4O4 (346.25799240000003)
(2r,3r,4r,5r)-2-{[(1s,2s,3r,4s,6r)-4,6-diamino-3-{[(2s,3r)-3-amino-6-[(methylamino)methyl]-3,4-dihydro-2h-pyran-2-yl]oxy}-2-hydroxycyclohexyl]oxy}-5-methyl-4-(methylamino)oxane-3,5-diol
(2s,3r,4s,5s,6r)-5-amino-6-{[(2r,3s,4r,5s)-5-{[(1r,2r,3s,5r,6s)-3-amino-2-{[(2r,3r,4r,5s,6r)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy}-5,6-dihydroxycyclohexyl]oxy}-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxy}-2-(aminomethyl)oxane-3,4-diol
[(1s,2r,3r,4s,5s)-5-[(3-acetylphenyl)amino]-4-amino-3-[n,n-dimethyl-(c-hydroxycarbonimidoyl)amino]-1,2-dihydroxy-3-[(1s)-1-hydroxyethyl]-2-methylcyclopentyl]methyl 2-hydroxy-6-methylbenzoate
(2r,3r,4s,5s)-2-{[(1s,2s,3r,4s,6r)-4,6-diamino-3-{[(2s,3r)-3-amino-6-(aminomethyl)-3,4-dihydro-2h-pyran-2-yl]oxy}-2-hydroxycyclohexyl]oxy}-4-(methylamino)oxane-3,5-diol
C18H35N5O7 (433.25363600000003)
2-{[6-({2-[(2,4-dicarbamimidamido-3,5,6-trihydroxycyclohexyl)oxy]-4-formyl-4-hydroxy-5-methyloxolan-3-yl}oxy)-4-hydroxy-2-(hydroxymethyl)-5-(methylamino)oxan-3-yl]oxy}-3,4-dihydroxy-5-(hydroxymethyl)oxolane-3-carboxylic acid
2-{[5-amino-2-(aminomethyl)-6-({5-[(3,5-diamino-2-{[3-amino-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-6-hydroxycyclohexyl)oxy]-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl}oxy)-4-hydroxyoxan-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
n-{3-carbamimidamido-4-[(4-formyl-4-hydroxy-3-{[4-hydroxy-6-(hydroxymethyl)-3-(methylamino)-5-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-5-methyloxolan-2-yl)oxy]-2,5,6-trihydroxycyclohexyl}guanidine
(2s,3'r,3ar,4s,4's,5'r,6s,6'r,7s,7ar)-6'-[(1r)-1-amino-2-hydroxyethyl]-4-{[(2r,3s,5s,6r)-2,6-dihydroxy-3,5-bis(methylamino)cyclohexyl]oxy}-6-(hydroxymethyl)-tetrahydro-3ah-spiro[[1,3]dioxolo[4,5-c]pyran-2,2'-oxane]-3',4',5',7-tetrol
4-amino-n-[(1r,2s,3r,4r,5s)-5-amino-4-{[(2r,3r,4r,5s,6r)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy}-3-{[(2s,3r,4r,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-2-hydroxycyclohexyl]-2-hydroxybutanimidic acid
(2r,3s,4s,5r,6s)-2-(hydroxymethyl)-6-{[(1s,2r,4r,5r,6r)-2,5,6-trihydroxy-2-(hydroxymethyl)-4-{[(1r,4r,5r,6s)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}cyclohexyl]oxy}oxane-3,4,5-triol
(2r,3r,4s,5s,6r)-2-{[(2r,3s,4r,4ar,6s,7r,8as)-7-amino-6-{[(1r,2r,3s,4r,6s)-4-amino-2,3,6-trihydroxycyclohexyl]oxy}-4-hydroxy-3-(methylamino)-octahydropyrano[3,2-b]pyran-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
2,8-dichloro-1-[(2r,3r,4r,5s,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]-5-hydroxy-6-methylchromeno[2,3-b]pyrrol-4-one
C19H19Cl2NO8 (459.04876740000003)
(2r,3s,4r,5r)-2-{[(1s,2r,3r,4s,6r)-4,6-diamino-2,3-dihydroxycyclohexyl]oxy}-5-methyl-4-(methylamino)oxane-3,5-diol
n-({[4-amino-3-({3-amino-6-[(ethylamino)methyl]oxan-2-yl}oxy)-2-hydroxy-6-methoxycyclohexyl](methyl)carbamoyl}methyl)carboximidic acid
2,6-dichloro-5-hydroxy-8-methyl-1-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]chromeno[2,3-b]pyrrol-4-one
C18H17Cl2NO8 (445.03311820000005)
(2s)-4-amino-n-(5-amino-4-{[3-amino-6-(1-aminoethyl)oxan-2-yl]oxy}-3-{[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-2-hydroxycyclohexyl)-2-hydroxybutanimidic acid
(2r,3r,4s,5s)-2-{[(1r,2r,3r,4s,6r)-4,6-diamino-3-{[(2s,3s,4r,5s,6r)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2-hydroxycyclohexyl]oxy}-5-methyl-4-(methylamino)oxane-3,5-diol
C19H38N4O10 (482.25878079999995)
2,6-dichloro-5-hydroxy-8-methyl-1-[(1r,4r,5s,6s)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]chromeno[2,3-b]pyrrol-4-one
C19H17Cl2NO7 (441.03820320000005)
n-(4-amino-3-{[3-amino-6-(1-aminoethyl)oxan-2-yl]oxy}-2-hydroxy-6-methoxycyclohexyl)-2-methanimidamido-n-methylacetamide
(2r,3r,4r,5r)-2-{[(1s,2s,3r,4s,6r)-4,6-diamino-3-{[(2r,3r,6s)-3-amino-6-(1-aminoethyl)oxan-2-yl]oxy}-2-hydroxycyclohexyl]oxy}-5-methyl-4-(methylamino)oxane-3,5-diol; gentamicin c1a; gentamycin c1
C60H123N15O21 (1389.9017508000002)
(2s)-4-amino-n-[5-amino-4-({3-amino-4,5-dihydroxy-6-[(methylamino)methyl]oxan-2-yl}oxy)-2,3-dihydroxycyclohexyl]-2-hydroxybutanimidic acid
5-amino-2-(aminomethyl)-6-({5-[(3,5-diamino-2-{[3-amino-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-6-hydroxycyclohexyl)oxy]-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl}oxy)oxane-3,4-diol
4-amino-n-(5-amino-4-{[3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy}-2-hydroxycyclohexyl)-2-hydroxybutanimidic acid
5-amino-6-[(6-amino-2-{[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-3,4-dihydroxycyclohexyl)oxy]-2-(aminomethyl)oxane-3,4-diol
C17H33N3O11 (455.21149879999996)
(2s,3r,4s,5s)-2-{[(1r,2s,3r,4s,6r)-4-amino-3-{[(2s,3r,6r)-3-amino-6-[(1s)-1-aminoethyl]oxan-2-yl]oxy}-2,6-dihydroxycyclohexyl]oxy}-5-methyl-4-(methylamino)oxane-3,5-diol
n-[2-({2-[(2,4-dicarbamimidamido-3,5,6-trihydroxycyclohexyl)oxy]-4-formyl-4-hydroxy-5-methyloxolan-3-yl}oxy)-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]-2-hydroxy-n-methylacetamide
C23H41N7O14 (639.2711366000001)
2,8-dichloro-1-[5,6-dihydroxy-3-(hydroxymethyl)-4-methoxycyclohex-2-en-1-yl]-5-hydroxy-6-methylchromeno[2,3-b]pyrrol-4-one
C20H19Cl2NO7 (455.05385240000004)
(2r,3s,4r,5r)-2-{[(2s,3r,4s,5s,6r)-6-{[(2s,3s,4r,5s)-2-{[(1s,2s,3r,4r,5r,6r)-2,4-dicarbamimidamido-3,5,6-trihydroxycyclohexyl]oxy}-4-formyl-4-hydroxy-5-methyloxolan-3-yl]oxy}-4-hydroxy-2-(hydroxymethyl)-5-(methylamino)oxan-3-yl]oxy}-3,4-dihydroxy-5-(hydroxymethyl)oxolane-3-carboxylic acid
(2r,3s,4r,5r,6r)-5-amino-6-{[(1r,2r,3s,4r,6s)-6-amino-2-{[(2s,3r,4s,5r)-4-{[(2r,3r,4r,5s,6s)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-3,4-dihydroxycyclohexyl]oxy}-2-(aminomethyl)oxane-3,4-diol
(2r,3'r,3as,4s,4's,5'r,6r,6'r,7s,7as)-4-{[(1s,2r,3s,5r,6s)-3-amino-2,6-dihydroxy-5-(methylamino)cyclohexyl]oxy}-6'-[(1r)-1-amino-2-hydroxyethyl]-6-(hydroxymethyl)-tetrahydro-3ah-spiro[[1,3]dioxolo[4,5-c]pyran-2,2'-oxane]-3',4',5',7-tetrol
(1r,2s,3s,4s,5r,6s)-4-amino-6-(hydroxymethyl)cyclohexane-1,2,3,5-tetrol
n-[(1s,2r,3r,4s,6s)-4-amino-3-{[(2r,3r,6s)-3-amino-6-[(methylamino)methyl]oxan-2-yl]oxy}-2-hydroxy-6-methoxycyclohexyl]-2-methanimidamido-n-methylacetamide
(2s,3r,4r,5s,6s)-2-(hydroxymethyl)-6-{[(1r,2r,3s,4r,5r,6s)-2,3,5-trihydroxy-6-(hydroxymethyl)-4-{[(1r,4s,5r,6r)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}cyclohexyl]oxy}oxane-3,4,5-triol
(2s)-4-amino-n-[(1r,2s,3r,4r,5s)-5-amino-4-{[(2r,3r,4r,5s,6r)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy}-3-{[(2s,3r,4r,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-2-hydroxycyclohexyl]-2-hydroxybutanimidic acid
2,6-dichloro-1-[(2r,3r,4r,5s,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]-5-hydroxy-8-methylchromeno[2,3-b]pyrrol-4-one
C19H19Cl2NO8 (459.04876740000003)
(1s,2s,3r,6s)-6-{[(3s,4r,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]amino}-4-(hydroxymethyl)cyclohex-4-ene-1,2,3-triol
(3'r,4s,4'r,5'r,6r,7s)-4-{[(1r,2s,3r,5s,6r)-3-amino-2,6-dihydroxy-5-(methylamino)cyclohexyl]oxy}-6'-[(1s)-1-amino-2-hydroxyethyl]-6-(hydroxymethyl)-tetrahydro-3ah-spiro[[1,3]dioxolo[4,5-c]pyran-2,2'-oxane]-3',4',5',7-tetrol
(2r,3r,4r,5s,6r)-5-amino-2-(aminomethyl)-6-{[(1r,2r,3s,4r,6s)-4,6-diamino-2-{[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-3-hydroxycyclohexyl]oxy}oxane-3,4-diol
n-[(1s,2r,3r,4r,6s)-4-amino-3-{[(2r,3r,6s)-3-amino-6-[(methylamino)methyl]oxan-2-yl]oxy}-2-hydroxy-6-methoxycyclohexyl]-2-methanimidamido-n-methylacetamide
(1r,2r,3r,4s,5r)-4-amino-5-(methylsulfanyl)cyclopentane-1,2,3-triol
n-[(1s,2r,3r,4s,6s)-4-amino-3-{[(2r,3r,6s)-3-amino-6-[(methylamino)methyl]oxan-2-yl]oxy}-2-hydroxy-6-methoxycyclohexyl]-2-(c-hydroxycarbonimidoylamino)-n-methylacetamide
2-[(4,6-diamino-2,3-dihydroxycyclohexyl)oxy]-5-methyl-4-(methylamino)oxane-3,5-diol
n-[(1r,2s,3s,4r,5r,6s)-3-carbamimidamido-2,4,5,6-tetrahydroxycyclohexyl]guanidine
C8H18N6O4 (262.13894680000004)
2,6-dichloro-5-hydroxy-8-methyl-1-[4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]chromeno[2,3-b]pyrrol-4-one
C19H17Cl2NO7 (441.03820320000005)
2-amino-n-[(1s,2r,3r,4s,5s,6r)-4-amino-3-{[(2r,3r,6s)-3-amino-6-(1-aminoethyl)oxan-2-yl]oxy}-2,5-dihydroxy-6-methoxycyclohexyl]-n-methylacetamide
C17H35N5O6 (405.25872100000004)
2,3,6-trichloro-5-hydroxy-8-methyl-1-[(1r,4r,5s,6s)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]chromeno[2,3-b]pyrrol-4-one
C19H16Cl3NO7 (474.99923160000003)
6'-(1-amino-2-hydroxyethyl)-4-[(3,5-diamino-2,6-dihydroxycyclohexyl)oxy]-6-(hydroxymethyl)-tetrahydro-3ah-spiro[[1,3]dioxolo[4,5-c]pyran-2,2'-oxane]-3',4',5',7-tetrol
5-amino-6-({5-[(3-amino-6-{[3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2-hydroxy-5-(methylamino)cyclohexyl)oxy]-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl}oxy)-2-(aminomethyl)oxane-3,4-diol
(2r,3r,4s,5s,6r)-2-{[(1s,2r,3r,4s,6s)-2,3-dihydroxy-6-(hydroxymethyl)-4-{[(1s,4s,5r,6r)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}cyclohexyl]oxy}-6-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxane-3,4,5-triol
(2r)-2-({[(1r)-1-{[(2r,3r,5s,6s)-4-{[(2s,3s,5s,6r)-3,5-diamino-6-methyloxan-2-yl]oxy}-2,3,5,6-tetrahydroxycyclohexyl]-c-hydroxycarbonimidoyl}-2-[(4s)-2-iminoimidazolidin-4-yl]ethyl]-c-hydroxycarbonimidoyl}amino)-4-methylpentanoic acid
[(1s,2r,3s,4s,5r,6s)-2,4-dicarbamimidamido-5-{[(2r,3r,4r,5s)-3-{[(2s,3s,4s,5r,6s)-4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy}-4-hydroxy-4-(hydroxymethyl)-5-methyloxolan-2-yl]oxy}-3,6-dihydroxycyclohexyl]oxyphosphonic acid
[(1s,2r,3s,4s,5s)-5-[(3-acetylphenyl)amino]-4-amino-3-[n,n-dimethyl-(c-hydroxycarbonimidoyl)amino]-3-ethyl-1,2-dihydroxy-2-methylcyclopentyl]methyl 2-hydroxy-6-methylbenzoate
(1s,2r,3r,4s,5s,6r)-2-amino-3-{[(2s,3r,6s)-3-amino-6-[(1s)-1-aminoethyl]oxan-2-yl]oxy}-6-methoxy-5-(methylamino)cyclohexane-1,4-diol
C15H32N4O5 (348.23725820000004)
(2s,3s,4r,5r,6r)-5-amino-6-{[(2r,3s,4r,5s)-5-{[(1r,2r,3s,5r,6s)-3-amino-2-{[(2s,3r,4r,5s,6r)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5,6-dihydroxycyclohexyl]oxy}-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxy}-2-(aminomethyl)oxane-3,4-diol
2-[(4,6-diamino-3-{[3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2-hydroxycyclohexyl)oxy]oxane-3,4,5-triol
C17H33N3O11 (455.21149879999996)
n-[(1s,2r,3r,4s,5r,6r)-3-carbamimidamido-6-{[(2r,3r,4r,5s)-3-{[(2s,3s,4s,5r,6s)-4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy}-4-formyl-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-2,4,5-trihydroxycyclohexyl]guanidine
n-[(2s,3s,4s,5r,6s)-2-{[(2r,3s,4s,5r)-2-{[(1s,2r,3s,4s,5s,6r)-2,4-dicarbamimidamido-3,5,6-trihydroxycyclohexyl]oxy}-4-formyl-4-hydroxy-5-methyloxolan-3-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]-2-hydroxy-n-methylacetamide
C23H41N7O14 (639.2711366000001)
(2s)-4-amino-n-(5-amino-4-{[3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy}-2-hydroxycyclohexyl)-2-hydroxybutanimidic acid
(2r,3r,4r,5r,6s)-6-{[(1r,2r,3s,4r,6s)-4,6-diamino-3-{[(2r,3r,6s)-6-(aminomethyl)-3-hydroxyoxan-2-yl]oxy}-2-hydroxycyclohexyl]oxy}-2-(hydroxymethyl)-3-methyl-4-(methylamino)oxane-3,5-diol
C20H40N4O9 (480.27951500000006)
n-{3-carbamimidamido-4-[(3-{[4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy}-4-formyl-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl)oxy]-2,5,6-trihydroxycyclohexyl}guanidine
[(2-{[4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4-[(5-{[6-(1,2-dihydroxyethyl)-3,4,5-trihydroxyoxan-2-yl]oxy}-4-hydroxy-3-(methylamino)oxan-2-yl)oxy]-3,6-dihydroxy-5-(c-hydroxycarbonimidoyloxy)cyclohexyl)oxy]methanimidic acid
(2s,3r,4r,5s,6s)-6-{[(1s,2s,3s,4r,6r)-4,6-diamino-3-{[(2r,3s,6r)-3-amino-6-[(methylamino)methyl]oxan-2-yl]oxy}-2-hydroxycyclohexyl]oxy}-2-(hydroxymethyl)-3-methyl-4-(methylamino)oxane-3,5-diol
3-amino-2-({3-amino-6-[(methylamino)methyl]oxan-2-yl}oxy)-5-methoxy-6-(methylamino)cyclohexan-1-ol
C15H32N4O4 (332.24234320000005)
[(1s,2r,3r,4s,5s)-4-amino-3-[n,n-dimethyl-(c-hydroxycarbonimidoyl)amino]-1,2-dihydroxy-5-{[3-(2-hydroxyacetyl)phenyl]amino}-3-(1-hydroxyethyl)-2-methylcyclopentyl]methyl 2-hydroxy-6-methylbenzoate
(n'-{5-amino-2-methyl-6-[(2,3,4,5,6-pentahydroxycyclohexyl)oxy]oxan-3-yl}carbamimidoyl)formic acid
C14H25N3O9 (379.15907200000004)
(2r,3s,4r,5r,6r)-5-amino-6-{[(1r,2r,3s,4r,6s)-6-amino-2-{[(2s,3r,4s,5r)-4-{[(2r,3s,4s,5r,6r)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy}-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-3,4-dihydroxycyclohexyl]oxy}-2-(aminomethyl)oxane-3,4-diol
2,8-dichloro-1-[(1r,4r,5r,6s)-5,6-dihydroxy-3-(hydroxymethyl)-4-methoxycyclohex-2-en-1-yl]-5-hydroxy-6-methylchromeno[2,3-b]pyrrol-4-one
C20H19Cl2NO7 (455.05385240000004)
2-[(4-amino-3-{[3-amino-6-(aminomethyl)oxan-2-yl]oxy}-2,6-dihydroxycyclohexyl)oxy]-5-methyl-4-(methylamino)oxane-3,5-diol
C19H38N4O8 (450.26895079999997)
4-amino-n-(5-amino-4-{[3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy}-3-{[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-2-hydroxycyclohexyl)-2-hydroxybutanimidic acid
(2r,3s,4r,5r,6r)-5-amino-6-{[(1r,2r,3s,4r,6s)-6-amino-2-{[(2s,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-3,4-dihydroxycyclohexyl]oxy}-2-(aminomethyl)oxane-3,4-diol
C17H33N3O11 (455.21149879999996)
n-[(2s,3r)-6-(aminomethyl)-2-{[(1r,2s,3s,4r,6s)-4,6-diamino-3-{[(2r,3r,4r,5r)-3,5-dihydroxy-5-methyl-4-(methylamino)oxan-2-yl]oxy}-2-hydroxycyclohexyl]oxy}-3,4-dihydro-2h-pyran-3-yl]carboximidic acid
5-amino-2-(aminomethyl)-6-[(2,4-diamino-5-{[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-3,6-dihydroxycyclohexyl)oxy]oxane-3,4-diol
(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-{[(1s,2s,3r,4s,5r)-2,3,4-trihydroxy-5-{[(1r,4s,5r,6s)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}cyclohexyl]methoxy}oxane-3,4,5-triol
C20H35NO13 (497.21083000000004)
2-[(4-amino-3-{[3-amino-6-(1-aminoethyl)oxan-2-yl]oxy}-2,6-dihydroxycyclohexyl)oxy]-5-methyl-4-(methylamino)oxane-3,5-diol
2-[(4,6-diamino-3-{[3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2-hydroxycyclohexyl)oxy]-5-methyl-4-(methylamino)oxane-3,5-diol
C19H38N4O10 (482.25878079999995)
(2s,3s,4r,5r,6r)-5-amino-2-(aminomethyl)-6-{[(2r,3r,4r,5s)-5-{[(1r,2r,3s,5r,6s)-3,5-diamino-2-{[(2s,3r,4r,5s,6r)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-6-hydroxycyclohexyl]oxy}-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxy}oxane-3,4-diol
(2s)-4-amino-n-[(1r,2s,3r,4r,5s)-5-amino-4-{[(2r,3r,4r,5s,6r)-6-(aminomethyl)-4,5-dihydroxy-3-[(1-hydroxyethylidene)amino]oxan-2-yl]oxy}-3-{[(2s,3r,4r,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-2-hydroxycyclohexyl]-2-hydroxybutanimidic acid
n-({[(1s,2r,3r,4r,6s)-4-amino-3-{[(2r,3r,6s)-3-amino-6-[(methylamino)methyl]oxan-2-yl]oxy}-2-hydroxy-6-methoxycyclohexyl](methyl)carbamoyl}methyl)carboximidic acid
C18H35N5O6 (417.25872100000004)
2-amino-3-{[3-amino-6-(aminomethyl)oxan-2-yl]oxy}-6-methoxy-5-(methylamino)cyclohexane-1,4-diol
(2s)-4-amino-n-[5-amino-4-({3-amino-4,5-dihydroxy-6-[(methylamino)methyl]oxan-2-yl}oxy)-3-{[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-2-hydroxycyclohexyl]-2-hydroxybutanimidic acid
(2s)-2-amino-4-{[(3s)-3-{[(1r,2s,3r,4r,5s)-5-amino-4-{[(2r,3r,4r,5s,6r)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy}-3-{[(2s,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-2-hydroxycyclohexyl]-c-hydroxycarbonimidoyl}-3-hydroxypropyl]-c-hydroxycarbonimidoyl}butanoic acid
(2r,3r,4s,5s,6s)-2-{[(2r,3s,4r,4ar,7r,8as)-7-amino-6-{[(1r,2r,3s,4r,6s)-4,6-diamino-2,3-dihydroxycyclohexyl]oxy}-4-hydroxy-3-(methylamino)-octahydropyrano[3,2-b]pyran-2-yl]oxy}-5-amino-6-(hydroxymethyl)oxane-3,4-diol
C21H41N5O11 (539.2802436000001)
n-[4-amino-3-({3-amino-6-[(methylamino)methyl]oxan-2-yl}oxy)-2-hydroxy-6-methoxycyclohexyl]-2-(c-hydroxycarbonimidoylamino)-n-methylacetamide
[(2s,3s,4r,5s)-5-{[(1r,2s,3r,4r,5s,6r)-2,4-dicarbamimidamido-3,5,6-trihydroxycyclohexyl]oxy}-4-{[(2s,3s,4s,5r,6s)-4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy}-2-methyloxolan-3-yl]methoxyphosphonic acid
n-[(1r,2s,3r,4r,5s,6r)-4-amino-3-{[(2r,3s,6s)-3-amino-6-[(1r)-1-aminoethyl]oxan-2-yl]oxy}-2,5-dihydroxy-6-methoxycyclohexyl]-2-methanimidamido-n-methylacetamide
2-[(6-{[2,3-dihydroxy-6-(hydroxymethyl)-4-{[4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}cyclohexyl]oxy}-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol
n-{4-[(3-{[3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4-formyl-4-hydroxy-5-methyloxolan-2-yl)oxy]-3-carbamimidamido-2,5,6-trihydroxycyclohexyl}guanidine
n-[(1s,2r,3r,4s,5r,6r)-3-carbamimidamido-6-{[(4r,5r,6r,8r,9r)-9-{[(2s,3s,4s,5r,6s)-4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy}-2,4-dihydroxy-6-methyl-1,7-dioxa-3-azaspiro[4.4]non-2-en-8-yl]oxy}-2,4,5-trihydroxycyclohexyl]guanidine
(2r,3r,4s,5s,6r)-5-amino-6-{[(2r,3s,4r,5s)-5-{[(1r,2r,3s,5r,6s)-3-amino-2-{[(2s,3r,4r,5s,6r)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5,6-dihydroxycyclohexyl]oxy}-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxy}-2-(aminomethyl)oxane-3,4-diol
n-[(1s,2r,3s,4s,5r,6s)-4-amino-3-{[(2r,3r,6r)-3-amino-6-[(1s)-1-aminoethyl]oxan-2-yl]oxy}-2,5-dihydroxy-6-methoxycyclohexyl]-2-(c-hydroxycarbonimidoylamino)-n-methylacetamide
4-amino-n-[(1r,2s,3r,4r,5s)-5-amino-4-{[(2r,3r,4r,5s,6r)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy}-3-{[(3r,4r,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-2-hydroxycyclohexyl]-2-hydroxybutanimidic acid
2-[(3,5-diamino-2-{[3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy}-6-hydroxycyclohexyl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol
C18H36N4O11 (484.23804659999996)
{[(1s,2s,3s,4s,5r,6r)-3-carbamimidamido-4-{[(2r,3r,4r,5s)-3-{[(2s,3s,4s,5r,6s)-4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy}-4-hydroxy-4-(hydroxymethyl)-5-methyloxolan-2-yl]oxy}-2,5,6-trihydroxycyclohexyl]oxy}methanimidic acid
n-[(1s,2r,3r,4s,5r,6r)-3-carbamimidamido-6-{[(2r,3r,4r,5s)-3-{[(2s,3s,4s,5r,6s)-4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy}-4-formyl-4-hydroxy-5-methyloxolan-2-yl]oxy}-2,4,5-trihydroxycyclohexyl]guanidine
n-[4-amino-3-({3-amino-6-[(methylamino)methyl]oxan-2-yl}oxy)-2-hydroxy-6-methoxycyclohexyl]-2-methanimidamido-n-methylacetamide
(2s,3r,4r,5s,6s)-6-{[(1r,2s,3r,4s,6s)-4,6-diamino-3-{[(2r,3s,6s)-3-amino-6-(aminomethyl)oxan-2-yl]oxy}-2-hydroxycyclohexyl]oxy}-2-(hydroxymethyl)-3-methyl-4-(methylamino)oxane-3,5-diol
C20H41N5O8 (479.29549860000003)
6,14,20,28-tetraamino-5,19-bis({[3,5-dihydroxy-5-methyl-4-(methylamino)oxan-2-yl]oxy})-2,16,29,30-tetraoxa-9,23-diazapentacyclo[23.3.1.1¹¹,¹⁵.0³,⁸.0¹⁷,²²]triaconta-9,11,23,25-tetraene-4,18-diol
C38H64N8O14 (856.4541763999999)
(1r,5s,6r)-4-amino-5-hydroxy-1-(hydroxymethyl)-7-oxabicyclo[4.1.0]hept-3-en-2-one
2,6-dichloro-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]-5-hydroxy-8-methylchromeno[2,3-b]pyrrol-4-one
C19H19Cl2NO8 (459.04876740000003)
n-[(2s,3r,4r,5s,6r)-5-{[(2s,3r,4r,5s,6r)-3-amino-5-{[(2s,3r,4r,5s,6r)-3-amino-5-{[(2s,3r,4r,5s,6r)-3-amino-5-{[(2s,3r,4r,5s,6r)-3-amino-5-{[(2s,3r,4r,5s,6r)-3-amino-5-{[(2s,3r,4r,5s,6r)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2-{[(2r,3s,4r,5r,6s)-5-amino-6-{[(2r,3s,4r,5r,6r)-5-amino-4,6-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}-4-hydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}-4-hydroxy-6-(hydroxymethyl)oxan-3-yl]methoxycarboximidic acid
C56H103N9O39 (1525.6352848000001)
2,6-dichloro-1-[(1r,4r,5r,6s)-5,6-dihydroxy-3-(hydroxymethyl)-4-methoxycyclohex-2-en-1-yl]-5-hydroxy-8-methylchromeno[2,3-b]pyrrol-4-one
C20H19Cl2NO7 (455.05385240000004)
(2s)-4-amino-n-(5-amino-4-{[3-amino-6-(aminomethyl)oxan-2-yl]oxy}-2,3-dihydroxycyclohexyl)-2-hydroxybutanimidic acid
(2s)-4-amino-n-[(1r,2s,3s,4r,5s)-5-amino-4-{[(2r,3r,4r,6r)-3-amino-6-(aminomethyl)-4-hydroxyoxan-2-yl]oxy}-2-{[(2s,3s,4r,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-3-hydroxycyclohexyl]-2-hydroxybutanimidic acid
C21H41N5O11 (539.2802436000001)
2-{[2,3-dihydroxy-6-(hydroxymethyl)-4-{[4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}cyclohexyl]oxy}-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxane-3,4,5-triol
n-{3-carbamimidamido-4-[(9-{[4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy}-2,4-dihydroxy-6-methyl-1,7-dioxa-3-azaspiro[4.4]non-2-en-8-yl)oxy]-2,5,6-trihydroxycyclohexyl}guanidine
4-amino-5-hydroxy-1-(hydroxymethyl)-7-oxabicyclo[4.1.0]hept-3-en-2-one
(1s,4r)-2-amino-3-{[(2r,3r,6s)-3-amino-6-(1-aminoethyl)oxan-2-yl]oxy}-6-methoxy-5-(methylamino)cyclohexane-1,4-diol
C15H32N4O5 (348.23725820000004)
2-amino-3-{[3-amino-6-(1-aminoethyl)oxan-2-yl]oxy}-6-methoxy-5-(methylamino)cyclohexane-1,4-diol
C15H32N4O5 (348.23725820000004)
4-(hydroxymethyl)-6-{[2,3,4-trihydroxy-5-(hydroxymethyl)cyclohexyl]amino}cyclohex-4-ene-1,2,3-triol
(2r,3s,4r,5r,6r)-5-amino-6-{[(1r,2r,3s,4r,6s)-6-amino-2-{[(2s,3r,4s,5r)-4-{[(2r,3s,4s,5r,6r)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-3,4-dihydroxycyclohexyl]oxy}-2-(aminomethyl)oxane-3,4-diol
6-{[4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]amino}-4-(hydroxymethyl)cyclohex-4-ene-1,2,3-triol
n-[(1s,2r,3r,4s,5r,6r)-3-carbamimidamido-6-{[(4s,5r,6r,8r,9r)-9-{[(2s,3s,4s,5r,6s)-4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy}-2,4-dihydroxy-6-methyl-1,7-dioxa-3-azaspiro[4.4]non-2-en-8-yl]oxy}-2,4,5-trihydroxycyclohexyl]guanidine
n-[6-(aminomethyl)-2-[(4,6-diamino-3-{[3,5-dihydroxy-5-methyl-4-(methylamino)oxan-2-yl]oxy}-2-hydroxycyclohexyl)oxy]-5,6-dihydro-4h-pyran-3-yl]carboximidic acid
2-amino-n-[4-amino-3-({3-amino-6-[(ethylamino)methyl]oxan-2-yl}oxy)-2-hydroxy-6-methoxycyclohexyl]-n-methylacetamide
C18H37N5O5 (403.27945520000003)
(2r,3r,4s,5s,6r)-2-{[(1s,2s,3r,4r,6s)-2,3-dihydroxy-6-(hydroxymethyl)-4-{[(4s,5r,6r)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}cyclohexyl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
C20H35NO13 (497.21083000000004)
2-{[4,6-diamino-3-({3-amino-6-[(methylamino)methyl]-3,4-dihydro-2h-pyran-2-yl}oxy)-2-hydroxycyclohexyl]oxy}-5-methyl-4-(methylamino)oxane-3,5-diol
4-amino-n-(5-amino-4-{[3-amino-6-(aminomethyl)-4-hydroxyoxan-2-yl]oxy}-3-{[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-2-hydroxycyclohexyl)-2-hydroxybutanimidic acid
C21H41N5O11 (539.2802436000001)
2,8-dichloro-1-[3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]-5-hydroxy-6-methylchromeno[2,3-b]pyrrol-4-one
C19H19Cl2NO8 (459.04876740000003)
2-[(4,6-diamino-3-{[3-amino-6-(aminomethyl)-3,4-dihydro-2h-pyran-2-yl]oxy}-2-hydroxycyclohexyl)oxy]-4-(methylamino)oxane-3,5-diol
C18H35N5O7 (433.25363600000003)
n-[(1s,2r,3r,4s,5r,6r)-3-carbamimidamido-6-{[(2r,3r,4r,5s)-3-{[(2s,3s,4s,5r,6s)-4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy}-4-hydroxy-4-(hydroxymethyl)-5-methyloxolan-2-yl]oxy}-2,4,5-trihydroxycyclohexyl]guanidine
C21H41N7O12 (583.2813066000001)
(2s)-4-amino-n-[(1r,2s,3s,4r,5s)-5-amino-2-{[(2s,3r,4s,5s,6r)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4-{[(2r,3r,4s,5s,6r)-6-(aminomethyl)-3,4,5-trihydroxyoxan-2-yl]oxy}-3-hydroxycyclohexyl]-2-hydroxybutanimidic acid
(2r,3r,4s,5r)-2-{[(1s,2s,3r,4s,6r)-4,6-diamino-3-{[(2s,3r)-3-amino-6-(aminomethyl)-3,4-dihydro-2h-pyran-2-yl]oxy}-2-hydroxycyclohexyl]oxy}-4-(methylamino)oxane-3,5-diol
C18H35N5O7 (433.25363600000003)
(2s,3s,4r,5r,6r)-5-amino-2-(aminomethyl)-6-{[(2r,3s,4r)-5-{[(1r,3s,5r,6s)-3,5-diamino-2-{[(2s,3r,4r,5s,6r)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-6-hydroxycyclohexyl]oxy}-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxy}oxane-3,4-diol
(2r,3r,4s,5s,6s)-2-{[(2s,3s,4r,5r,6r)-6-{[(1r,2s,3s,4s,6r)-2,3-dihydroxy-6-(hydroxymethyl)-4-{[(1s,4s,5r,6r)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}cyclohexyl]oxy}-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
n-{3-amino-5-[6'-(1-amino-2-hydroxyethyl)-6-(hydroxymethyl)-tetrahydro-3ah-spiro[[1,3]dioxolo[4,5-c]pyran-2,2'-oxane]-3',4',5',7-tetroloxy]-2,4,6-trihydroxycyclohexyl}guanidine
2-amino-n-[(1s,2r,3r,4s,5r,6s)-4-amino-3-{[(2r,3r,6r)-3-amino-6-(aminomethyl)oxan-2-yl]oxy}-2,5-dihydroxy-6-methoxycyclohexyl]-n-methylacetamide
n-({[(1s,2r,3r,4s,6s)-4-amino-3-{[(2r,3r,6s)-3-amino-6-[(ethylamino)methyl]oxan-2-yl]oxy}-2-hydroxy-6-methoxycyclohexyl](methyl)carbamoyl}methyl)carboximidic acid
2-{[4-amino-3-({3-amino-6-[(methylamino)methyl]oxan-2-yl}oxy)-2,6-dihydroxycyclohexyl]oxy}-5-methyl-4-(methylamino)oxane-3,5-diol
(2r,3s,4s,5s)-2-{[(1s,2s,3r,4s,6r)-4,6-diamino-3-{[(2s,3r,4r,5s,6r)-3-amino-4,5-dihydroxy-6-[(1r)-1-hydroxyethyl]oxan-2-yl]oxy}-2-hydroxycyclohexyl]oxy}-5-methyl-4-(methylamino)oxane-3,5-diol
C20H40N4O10 (496.27443000000005)
6'-(1-amino-2-hydroxyethyl)-4-{[2,6-dihydroxy-3,5-bis(methylamino)cyclohexyl]oxy}-6-(hydroxymethyl)-tetrahydro-3ah-spiro[[1,3]dioxolo[4,5-c]pyran-2,2'-oxane]-3',4',5',7-tetrol
n-[(5r)-4-amino-3-{[3-amino-6-(1-aminoethyl)oxan-2-yl]oxy}-2,5-dihydroxy-6-methoxycyclohexyl]-2-methanimidamido-n-methylacetamide
2-amino-n-[4-amino-3-({3-amino-6-[(ethylamino)methyl]oxan-2-yl}oxy)-2-hydroxy-6-methoxycyclohexyl]-n-methylacetamide; carbonic acid
n-({[4-amino-3-({3-amino-6-[(methylamino)methyl]oxan-2-yl}oxy)-2-hydroxy-6-methoxycyclohexyl](methyl)carbamoyl}methyl)carboximidic acid
C18H35N5O6 (417.25872100000004)
2-{[2,4-diamino-5-({3-amino-6-[(methylamino)methyl]oxan-2-yl}oxy)-3,6-dihydroxycyclohexyl]oxy}-5-methyl-4-(methylamino)oxane-3,5-diol
C20H41N5O8 (479.29549860000003)
n-[(1s,2r,3r,4s,5r,6r)-3-carbamimidamido-6-{[(2r,3r,4r,5s)-4-formyl-4-hydroxy-3-{[(2s,3s,4s,5r,6s)-4-hydroxy-6-(hydroxymethyl)-3-(methylamino)-5-{[(2r,3s,4s,5s,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-5-methyloxolan-2-yl]oxy}-2,4,5-trihydroxycyclohexyl]guanidine
(1s,2s,3s,4r,5s,6r)-6-amino-2-(hydroxymethyl)cyclohexane-1,2,3,4,5-pentol
(1s,2s,3r,4s,5s)-5-amino-1-(hydroxymethyl)cyclohexane-1,2,3,4-tetrol
(1r,3s,4s,5r,6s,8r,14r,15s,17r,18r,19s,20r,22s,28s)-6,14,20,28-tetraamino-5,19-bis({[(2r,3r,4r,5r)-3,5-dihydroxy-5-methyl-4-(methylamino)oxan-2-yl]oxy})-2,16,29,30-tetraoxa-9,23-diazapentacyclo[23.3.1.1¹¹,¹⁵.0³,⁸.0¹⁷,²²]triaconta-9,11,23,25-tetraene-4,18-diol
C38H64N8O14 (856.4541763999999)
4-amino-n-[(1r,2s,3r,4r,5s)-5-amino-4-{[(2r,3r,4r,5s,6r)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy}-3-{[(2s,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-2-hydroxycyclohexyl]-2-hydroxybutanimidic acid
1-(hydroxymethyl)-5-{[4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}cyclohexane-1,2,3,4-tetrol
{n'-[(2r,3s,5s,6r)-5-amino-2-methyl-6-{[(2r,3s,5s,6s)-2,3,4,5,6-pentahydroxycyclohexyl]oxy}oxan-3-yl]carbamimidoyl}formic acid
C14H25N3O9 (379.15907200000004)
2,3,6-trichloro-5-hydroxy-8-methyl-1-[4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]chromeno[2,3-b]pyrrol-4-one
C19H16Cl3NO7 (474.99923160000003)
2,6-dichloro-5-hydroxy-8-methyl-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]chromeno[2,3-b]pyrrol-4-one
C18H17Cl2NO8 (445.03311820000005)
{5-[(3-acetylphenyl)amino]-4-amino-3-[n,n-dimethyl-(c-hydroxycarbonimidoyl)amino]-1,2-dihydroxy-3-(1-hydroxyethyl)-2-methylcyclopentyl}methyl 2-hydroxy-6-methylbenzoate
2-amino-n-[4-amino-3-({3-amino-6-[(methylamino)methyl]oxan-2-yl}oxy)-2-hydroxy-6-methoxycyclohexyl]-n-methylacetamide
C17H35N5O5 (389.26380600000005)
4-amino-n-(5-amino-4-{[6-(aminomethyl)-4,5-dihydroxy-3-[(1-hydroxyethylidene)amino]oxan-2-yl]oxy}-3-{[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-2-hydroxycyclohexyl)-2-hydroxybutanimidic acid
2-(hydroxymethyl)-6-[(2,3,4-trihydroxy-5-{[4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}cyclohexyl)methoxy]oxane-3,4,5-triol
C20H35NO13 (497.21083000000004)